Bio-Techne Corporation
NASDAQ:TECH
Overview | Financials
Company Name | Bio-Techne Corporation |
Symbol | TECH |
Currency | USD |
Price | 74.41 |
Market Cap | 11,823,153,720 |
Dividend Yield | 0.38% |
52-week-range | 58.99 - 85.57 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Charles R. Kummeth |
Website | https://www.bio-techne.com |
An error occurred while fetching data.
About Bio-Techne Corporation
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD